These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2036032

  • 1. T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells.
    Miyauchi H, Hosokawa H, Akaeda T, Iba H, Asada Y.
    Arch Dermatol; 1991 Jun; 127(6):851-5. PubMed ID: 2036032
    [Abstract] [Full Text] [Related]

  • 2. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine.
    Friedmann PS, Strickland I, Pirmohamed M, Park BK.
    Arch Dermatol; 1994 May; 130(5):598-604. PubMed ID: 8179341
    [Abstract] [Full Text] [Related]

  • 3. Delayed hypersensitivity in ampicillin-induced toxic epidermal necrolysis.
    Tagami H, Tatsuta K, Iwatski K, Yamada M.
    Arch Dermatol; 1983 Nov; 119(11):910-3. PubMed ID: 6639111
    [Abstract] [Full Text] [Related]

  • 4. Lymphocyte subsets and Langerhans' cells in toxic epidermal necrolysis. Report of a case.
    Merot Y, Gravallese E, Guillén FJ, Murphy GF.
    Arch Dermatol; 1986 Apr; 122(4):455-8. PubMed ID: 2937370
    [Abstract] [Full Text] [Related]

  • 5. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption.
    Mizukawa Y, Yamazaki Y, Shiohara T.
    Br J Dermatol; 2008 Jun; 158(6):1230-8. PubMed ID: 18363767
    [Abstract] [Full Text] [Related]

  • 6. Impaired antigen presentation in toxic epidermal necrolysis.
    Bagot M, Charue D, Heslan M, Wechsler J, Roujeau JC, Revuz J.
    Arch Dermatol; 1993 Jun; 129(6):721-7. PubMed ID: 8507074
    [Abstract] [Full Text] [Related]

  • 7. Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement.
    Correia O, Delgado L, Ramos JP, Resende C, Torrinha JA.
    Arch Dermatol; 1993 Apr; 129(4):466-8. PubMed ID: 8466217
    [Abstract] [Full Text] [Related]

  • 8. T-cell subsets in drug-induced toxic epidermal necrolysis.
    Hertl M, Merk HF, Bohlen H.
    Arch Dermatol; 1992 Feb; 128(2):272. PubMed ID: 1590854
    [No Abstract] [Full Text] [Related]

  • 9. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P.
    Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
    [Abstract] [Full Text] [Related]

  • 10. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis.
    Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Piérard GE.
    Arch Dermatol; 1994 May; 130(5):605-8. PubMed ID: 8179342
    [Abstract] [Full Text] [Related]

  • 11. Immunological mechanisms of epidermal damage in toxic epidermal necrolysis.
    Tohyama M, Hashimoto K.
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):376-82. PubMed ID: 22688730
    [Abstract] [Full Text] [Related]

  • 12. Expression of α-defensin 1-3 in T cells from severe cutaneous drug-induced hypersensitivity reactions.
    Morel E, Alvarez L, Cabañas R, Fiandor A, Díaz R, Escamochero S, Prior N, Blanca M, Bellón T.
    Allergy; 2011 Mar; 66(3):360-7. PubMed ID: 20880148
    [Abstract] [Full Text] [Related]

  • 13. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions.
    Tapia B, Padial A, Sánchez-Sabaté E, Alvarez-Ferreira J, Morel E, Blanca M, Bellón T.
    J Allergy Clin Immunol; 2004 Aug; 114(2):335-40. PubMed ID: 15316512
    [Abstract] [Full Text] [Related]

  • 14. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Borchers AT, Lee JL, Naguwa SM, Cheema GS, Gershwin ME.
    Autoimmun Rev; 2008 Sep; 7(8):598-605. PubMed ID: 18603022
    [Abstract] [Full Text] [Related]

  • 15. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
    Baadsgaard O, Fox DA, Cooper KD.
    J Immunol; 1988 Mar 15; 140(6):1738-44. PubMed ID: 2964481
    [Abstract] [Full Text] [Related]

  • 16. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ, Seyger MM, Van de Kerkhof PC.
    Br J Dermatol; 2005 Jul 15; 153(1):72-8. PubMed ID: 16029329
    [Abstract] [Full Text] [Related]

  • 17. Drug-induced toxic epidermal necrolysis and pancytopenia: a puzzling association.
    Paquet P, Jacob E, Pirson J, Pierard GE.
    Int J Mol Med; 2005 Jul 15; 16(1):29-33. PubMed ID: 15942674
    [Abstract] [Full Text] [Related]

  • 18. Animal models of toxic epidermal necrolysis.
    Azukizawa H.
    J Dermatol; 2011 Mar 15; 38(3):255-60. PubMed ID: 21342227
    [Abstract] [Full Text] [Related]

  • 19. Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis.
    Paquet P, Jacob E, Damas P, Pirson J, Piérard G.
    Arch Dermatol Res; 2005 Dec 15; 297(6):266-73. PubMed ID: 16249890
    [Abstract] [Full Text] [Related]

  • 20. Delayed hypersensitivity in drug-induced toxic epidermal necrolysis.
    Roujeau JC, Bagot M, Revuz J, Touraine R.
    Arch Dermatol; 1984 Nov 15; 120(11):1417-8. PubMed ID: 6497406
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.